Concord Biotech Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONCORD BIOTECH LTD, and what generic and branded alternatives to CONCORD BIOTECH LTD drugs are available?
CONCORD BIOTECH LTD has four approved drugs.
Summary for Concord Biotech Ltd
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
| Drug Master File Entries: | 16 |
Drugs and US Patents for Concord Biotech Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Biotech Ltd | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 211173-001 | Dec 13, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Concord Biotech Ltd | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 213112-003 | Nov 10, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Concord Biotech Ltd | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 211173-002 | Dec 13, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Concord Biotech Ltd | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 212087-001 | Jul 31, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
